Marzena Jurek, M.S.
Marzena Jurek, M.S., joined Pliant in March 2019 as vice president of clinical operations to oversee tactical implementation of Pliant’s clinical programs. She brings to Pliant 20 years broad experience in clinical development and pre-clinical research in mid and small/start-up companies. Ms. Jurek previously oversaw and managed early and late-stage global programs in several rare disease indications, including hepatic encephalopathy, idiopathic pulmonary fibrosis, and sickle cell disease. She has held positions of increasing responsibility at Portola Pharmaceuticals, Hyperion Therapeutics, and most recently Global Blood Therapeutics, among others, managing cross-functional teams and overseeing deployment of clinical programs.